These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 12446475)
1. Structural diversity of cancer-related and non-cancer-related prostate-specific antigen. Isono T; Tanaka T; Kageyama S; Yoshiki T Clin Chem; 2002 Dec; 48(12):2187-94. PubMed ID: 12446475 [TBL] [Abstract][Full Text] [Related]
2. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Peracaula R; Tabarés G; Royle L; Harvey DJ; Dwek RA; Rudd PM; de Llorens R Glycobiology; 2003 Jun; 13(6):457-70. PubMed ID: 12626390 [TBL] [Abstract][Full Text] [Related]
3. Strategy for sensitive and specific detection of molecular forms of PSA based on 2DE and kinetic analysis: a step towards diagnosis of prostate cancer. Kumar V; Hassan MI; Singh AK; Dey S; Singh TP; Yadav S Clin Chim Acta; 2009 May; 403(1-2):17-22. PubMed ID: 19118539 [TBL] [Abstract][Full Text] [Related]
4. Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications. Jung K; Brux B; Lein M; Rudolph B; Kristiansen G; Hauptmann S; Schnorr D; Loening SA; Sinha P Clin Chem; 2000 Jan; 46(1):47-54. PubMed ID: 10620571 [TBL] [Abstract][Full Text] [Related]
5. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach. Tajiri M; Ohyama C; Wada Y Glycobiology; 2008 Jan; 18(1):2-8. PubMed ID: 17956937 [TBL] [Abstract][Full Text] [Related]
6. Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Bélanger A; van Halbeek H; Graves HC; Grandbois K; Stamey TA; Huang L; Poppe I; Labrie F Prostate; 1995 Oct; 27(4):187-97. PubMed ID: 7479385 [TBL] [Abstract][Full Text] [Related]
7. Glycan characterization of PSA 2-DE subforms from serum and seminal plasma. Sarrats A; Saldova R; Comet J; O'Donoghue N; de Llorens R; Rudd PM; Peracaula R OMICS; 2010 Aug; 14(4):465-74. PubMed ID: 20726802 [TBL] [Abstract][Full Text] [Related]
8. Analysis of free prostate-specific antigen (PSA) after chemical release from the complex with alpha(1)-antichymotrypsin (PSA-ACT). Peter J; Unverzagt C; Hoesel W Clin Chem; 2000 Apr; 46(4):474-82. PubMed ID: 10759471 [TBL] [Abstract][Full Text] [Related]
9. Molecular heterogeneity of free PSA in sera of patients with benign and malignant prostate tumors. Hilz H; Noldus J; Hammerer P; Buck F; Lück M; Huland H Eur Urol; 1999 Oct; 36(4):286-92. PubMed ID: 10473986 [TBL] [Abstract][Full Text] [Related]
10. On chip immuno-affinity profiling of cancer- and benign hyperplasia-associated free prostate specific antigen. Kosanovic MM; Goc SR; Potpara GS; Jankovic MM Dis Markers; 2011; 31(2):111-8. PubMed ID: 21897005 [TBL] [Abstract][Full Text] [Related]
11. Identification of precursor forms of free prostate-specific antigen in serum of prostate cancer patients by immunosorption and mass spectrometry. Peter J; Unverzagt C; Krogh TN; Vorm O; Hoesel W Cancer Res; 2001 Feb; 61(3):957-62. PubMed ID: 11221890 [TBL] [Abstract][Full Text] [Related]
12. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396 [TBL] [Abstract][Full Text] [Related]
13. Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry. Végvári Á; Rezeli M; Sihlbom C; Häkkinen J; Carlsohn E; Malm J; Lilja H; Laurell T; Marko-Varga G Clin Biochem; 2012 Mar; 45(4-5):331-8. PubMed ID: 22209970 [TBL] [Abstract][Full Text] [Related]
14. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection. Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783 [TBL] [Abstract][Full Text] [Related]
15. A novel form of prostate-specific antigen transcript produced by alternative splicing. Tanaka T; Isono T; Yoshiki T; Yuasa T; Okada Y Cancer Res; 2000 Jan; 60(1):56-9. PubMed ID: 10646852 [TBL] [Abstract][Full Text] [Related]
16. Structural characterization and anti-angiogenic properties of prostate-specific antigen isoforms in seminal fluid. Mattsson JM; Valmu L; Laakkonen P; Stenman UH; Koistinen H Prostate; 2008 Jun; 68(9):945-54. PubMed ID: 18386289 [TBL] [Abstract][Full Text] [Related]
17. Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia. Mikolajczyk SD; Millar LS; Marker KM; Wang TJ; Rittenhouse HG; Marks LS; Slawin KM Prostate; 2000 Nov; 45(3):271-6. PubMed ID: 11074531 [TBL] [Abstract][Full Text] [Related]
18. Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids. White KY; Rodemich L; Nyalwidhe JO; Comunale MA; Clements MA; Lance RS; Schellhammer PF; Mehta AS; Semmes OJ; Drake RR J Proteome Res; 2009 Feb; 8(2):620-30. PubMed ID: 19128049 [TBL] [Abstract][Full Text] [Related]
19. Thiophilic interaction chromatography facilitates detection of various molecular complexes of prostate-specific antigen in biological fluids. Kawinski E; Levine E; Chadha K Prostate; 2002 Feb; 50(3):145-53. PubMed ID: 11813206 [TBL] [Abstract][Full Text] [Related]
20. Prostate specific antigen in benign prostatic hyperplasia: purification and characterization. Chen Z; Chen H; Stamey TA J Urol; 1997 Jun; 157(6):2166-70. PubMed ID: 9146608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]